Latest Corporate Presentation Corporate Presentation January 2021
Analyst reports
Documents
Videos and webcasts
07-Dec-2020
CEO Lisa Anson discussed £25.5m raise to drive forward key programmes
10-Jun-2020
Chief Medical Officer, Dr Andrew Saunders, provides updates on lead oncology asset RXC004
Latest
09-Jun-2020
Chief Scientific Officer Richard Armer provides updates on lead fibrosis asset RXC007 which has potential for development in multiple fibrotic conditions
News & events
Our scientific publications
Investor centre
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies. Cookie Policy.
